跳至主要内容
临床试验/NCT03967158
NCT03967158进行中(未招募)不适用

Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY

Seung-Jung Park10 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2019年12月23日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
2,000
试验地点
10
主要终点
Composite event rate of death, non-fatal myocardial infarction (MI), or Target- Vessel Revascularization (TVR)

研究概览

简要总结

The objective of this study is to evaluate effectiveness and safety of Xience Sierra stent in the "real world" daily practice as compared with other drug-eluting stents.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 19 and more
  • Patient with Xience Sierra Everolimus eluting coronary stent
  • Written consent

排除标准

  • Intervention with Xience Sierra Everolimus eluting coronary stent and other drug eluting stent at the same time
  • Life-expectancy less than 1 year
  • Cardiac shock

结局指标

主要结局

Composite event rate of death, non-fatal myocardial infarction (MI), or Target- Vessel Revascularization (TVR)

时间窗: 1 year

次要结局

  • Target- Lesion Revascularization(5 year)
  • Myocardial Infarction(5 year)
  • Stent thrombosis(5 year)
  • Target- Vessel Revascularization(5 year)
  • Cardiac death(5 year)
  • Composite event rate of cardiac death or myocardial infarction (MI)(5 year)
  • Stroke(5 year)
  • All cause death(5 year)
  • Procedural Success rate(5 year)
  • Composite event rate of death or myocardial infarction (MI)(5 year)

研究者

发起方
Seung-Jung Park
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Seung-Jung Park

Professor, Division of Interventional Cardiology. Cardiovascular Center, Asan Medical Center. University of Ulsan, College of Medicine

Asan Medical Center

研究点 (10)

Loading locations...

相似试验